Discovery of JNJ-787: An Hpk1 inhibitor that enhances the anti-tumor immunity of anti-PD1 in mice

被引：0
|
作者：
Mevellec, Laurence [2 ]
Descamps, Sophie [2 ]
Adelinet, Christophe [2 ]
Wroblowski, Berthold [1 ]
Vreys, Veronique [1 ]
Valckx, Annemie [1 ]
Boeckx, Inge [1 ]
Van Slycken, Nele [1 ]
Paulussen, Caroline [1 ]
Leclercq, Laurent [1 ]
Verhulst, Tinne [1 ]
Van der Leede, Bas-jan [1 ]
Angibaud, Patrick [2 ]
Meerpoel, Lieven [1 ]
Edwards, James [3 ]
Laquerre, Sylvie [3 ]
Lorenzi, Matt [3 ]
Vialard, Jorge [1 ]
机构：
[1] Janssen Res & Dev, Beerse, Belgium
[2] Janssen Res & Dev, Val De Reuil, France
[3] Janssen Res & Dev, Spring House, PA USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2019年 / 257卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
5
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A highly potent HPK1 inhibitor augments immune cell activation and anti-tumor immunity in a syngeneic tumor mouse model
    Liu, Hao
    Wu, Lei
    Feng, Song
    Huang, Wei
    Li, Huijuan
    Lin, Jing
    Liu, Yangyang
    Mei, Liufeng
    Ren, Baoqi
    Xie, Julie
    Yao, Lili
    Zhong, Wenge
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [2] DSP-0692, a selective SCD inhibitor, enhances the anti-tumor activity of anti-PD1 antibody
    Sugaru, Eiji
    Furuta, Yudai
    Nagagaki, Yoshikazu
    Ikeda, Satoshi
    Fukunaga, Yuichi
    Urnehara, Hiroki
    Otsubo, Tsuguteru
    Watanabe, Manabu
    Tojo, Shingo
    Hashizume, Miki
    Matsuki, Yasushi
    Ban, Hitoshi
    CANCER RESEARCH, 2019, 79 (13)
  • [3] Novel small molecule HPK1 inhibitor induces immunogenic anti-tumor effects.
    Chaudhari, Sachin S.
    Bajpai, Malini
    Mandadi, Sravan
    Kattige, Vidya G.
    Thorat, Sandeep
    Potdar, Varada
    Pangre, Priyanka
    Sawant, Pooja
    Misra, Chandrasekhar
    Das, Subhadip
    Akarte, Atul
    Singh, Anuj
    Mahankali, Sandeep
    Lambade, Pandurang
    Das, Avratanu
    Patole, Raju
    Udupa, Venkatesha
    Sancheti, Pavankumar
    Pawar, Pramod K.
    Kakade, Somesh
    Vinod, K. R.
    Biswas, Nilanjana
    Shah, Heta
    Behera, Dayanidhi
    Jain, Pankaj
    Gowda, Nagaraj
    Iyer, Pravin S.
    CANCER RESEARCH, 2021, 81 (13)
  • [4] NOVEL SMALL MOLECULE HPK1 INHIBITOR PCC-1 INDUCES STRONG ANTI-TUMOR ACTIVITY
    Das, Sanjib
    Mandadi, Sravan
    Saini, Jagmohan
    Chaudhari, Sachin
    Deshpande, Ameya
    Chinnapattu, Murugan
    Bajpai, Malini
    Pangre, Priyanka
    Potdar, Varada
    Marathe, Megha
    Sawant, Pooja
    Akarte, Atul
    Misra, Chandrasekhar
    Das, Subhadip
    Singh, Anuj
    Das, Avratanu
    Lambade, Pandurang
    Tirumalasetty, Chaitanya
    Patole, Raju
    Biswas, Nilanjana
    Karande, Vikas
    Shah, Heta
    Behera, Dayanidhi
    Gowda, Nagaraj
    Iyer, Pravin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A889 - A889
  • [5] The role of HPK1 in the regulation of T cell function and anti-tumor immune activity
    Chen, Yaoyu
    Rios-Doria, Jonathan
    Pusey, Michelle
    Lasky, Kerri
    Ye, Min
    Thekkat, Pramod
    Gallagher, Karen
    Stump, Kristine
    Conlen, Patricia
    Gardiner, Christine
    Wang, Hui
    Sokolsky, Alexander
    Rupar, Mark
    Lin, Luping
    Behshad, Elham
    Covington, Maryanne
    Koblish, Holly
    Vechorkin, Oleg
    Yao, Wenqing
    Kim, Sunkyu
    Chen, Yingnan
    CANCER RESEARCH, 2020, 80 (16)
  • [6] Neuritin-specific antibody impedes the Treg-mediated suppression of anti-tumor immunity and enhances response to anti-PD1
    Zhang, Kaimin
    Zhao, Taowen
    Riaz, Fraooq
    Li, Yikui
    Wei, Ping
    Fang, Xiang
    Zhou, Zhiyi
    Kou, Wei
    Pan, Fan
    MOLECULAR IMMUNOLOGY, 2025, 181 : 148 - 159
  • [7] An Oral PROTAC Targeting HPK1 Degradation Potentiates Anti-Solid Tumor Immunity
    Yao, Yuejun
    Wu, Mingfei
    Wang, Yanfang
    Liao, Ziyan
    Yang, Yinxian
    Liu, Yun
    Shi, Jiaqi
    Wu, Wei
    Wei, Xinwei
    Xu, Jianchang
    Guo, Yugang
    Dong, Xiaowu
    Che, Jinxin
    Wang, Jinqiang
    Gu, Zhen
    ADVANCED MATERIALS, 2024,
  • [8] Discovery of novel, potent, selective and orally bioavailable HPK1 inhibitor for enhancing the efficacy of anti-PD-L1 antibody
    Zeng, Shenxin
    Wu, Mingfei
    Jin, Yuyuan
    Ye, Yingqiao
    Xia, Heye
    Chen, Xinyi
    Che, Jinxin
    Wang, Zunyuan
    Wu, Ying
    Dong, Xiaowu
    Chen, Yinqiao
    Huang, Wenhai
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 267
  • [9] BET inhibitor JQ1 enhances anti-tumor immunity and synergizes with PD-1 blockade in CRC
    Wang, Huijin
    Liu, Guangyao
    Jin, Xinghan
    Song, Shenglei
    Chen, Songyao
    Zhou, Peiqing
    Li, Huan
    Liang, Jianming
    Li, Bo
    Zhang, Changhua
    He, Yulong
    JOURNAL OF CANCER, 2022, 13 (06): : 2126 - 2137
  • [10] NDI-101150 is a potent and highly selective HPK1 inhibitor that both synergizes with and differentiates from anti-PD1 immune checkpoint blockade
    Ciccone, David
    Kuo, Fu-Shan
    Daigle, Scott
    Kaila, Neelu
    Yau, Gene
    Carlson, Mark
    Levasseur, Denise
    Srivastava, Bhaskar
    Basile, Frank G.
    Loh, Christine
    CANCER RESEARCH, 2024, 84 (06)
12345